Pfizer

Showing 15 posts of 894 posts found.

Hospira image

Pfizer to buy Hospira for $17 billion

February 5, 2015
Sales and Marketing Hospira, Humira, Pfizer, acquisition, biosimilars, merger

Pfizer has struck a deal with Hospira to acquire the company in a deal worth around $17 billion. Industry analysts …

Pfizer gets early approval for breast cancer drug

February 4, 2015
Sales and Marketing FDA, Pfizer, Xalkori (crizotinib), axitinib, bosulif, bosutinib, femara, ibrance, inlyta, letrozole, palbociclib

The FDA has shown Pfizer’s breast cancer drug Ibrance an early green light to treat patients who are at the …

Pfizer image

Pfizer posts fourth-quarter revenue decline

January 28, 2015
Sales and Marketing Eliquis, Lipitor, Lyrica (pregablin), Pfizer, Read, Xeljanz, apixaban, financials, pneumococcal vaccine Prevnar, q4, tofacitinib citrate

Pfizer posted a 3% decline in revenue in the last quarter of 2014, the company’s latest financial results show. The …

Vaccine image

Pharma firms pledge vaccine support for developing countries

January 27, 2015
Manufacturing and Production, Research and Development, Sales and Marketing GAVI, GSK, Janssen, Médecins Sans Frontières, Pfizer, Vaccine

Several pharma firms have announced commitments to help Gavi, the global vaccine alliance, to increase immunisation of children in developing …

Pfizer image

MSF hits out at ‘astronomical’ vaccine prices

January 20, 2015
Research and Development, Sales and Marketing Doctors Without Borders, GSK, Médicines San Frontières, Pfizer, Vaccine, diphtheria, measles, pertussis, poliomyelitis, tetanus, tuberculosis

Pharma companies have been named and shamed in a report calling on manufacturers to lower the cost of childhood vaccines …

Daiichi image

Daiichi-Sankyo blood drug gets FDA nod

January 12, 2015
Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa

The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …

23andme image

Genentech makes $10m gene testing outlay

January 8, 2015
Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, MHRA, Pfizer, Roche

Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …

Pfizer buys vaccine developer Redvax

January 6, 2015
Research and Development, Sales and Marketing Pfizer, Vaccine, cmv, herpes, redbiotec, redvax, virus

Adding to its latest string of deals Pfizer has acquired vaccine developer Redvax – the pre-clinical arm of Swiss company …

Pfizer image

New Lyrica formulation effective in trials

December 19, 2014
Sales and Marketing HIV, Lyrica, Pfizer, pain, pregabalin, shingles

Pfizer has reported positive Phase III results for a new formulation of its painkiller Lyrica. In the study, a controlled-release …

research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014
Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …

Inlyta image

NICE backs Pfizer’s drug for advanced kidney cancer

December 16, 2014
Sales and Marketing NICE, Pfizer, Sutent, Votrient, Zytiga, axitinib, inlyta, xofigo

UK healthcare guidance body NICE has issued final draft guidance recommending Pfizer’s Inlyta for advanced kidney cancer. The draft recommendation …

Pfizer image

Pfizer buys OPKO growth hormone drug

December 16, 2014
Research and Development, Sales and Marketing Pfizer, ghd, growth, hGH-CTP, hormone, merger, opko

Pfizer will co-develop and commercialise OPKO’s growth hormone deficiency (GHD) drug hGH-CTP in a new agreement between the firms. The …

Pfizer buys into gene therapy

December 9, 2014
Research and Development, Sales and Marketing London, Pfizer, gene therapy, haemophilia, spark, therapeutics

Pfizer has announced that it is establishing a gene therapy platform as it looks to expand its rare diseases operations. …

AZ image

AZ predicts strong growth ahead of Pfizer deadline

November 19, 2014
Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens

AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …

Pfizer signs $3 billion cancer deal

November 18, 2014
Research and Development, Sales and Marketing Cancer, Merck KGaA, PD-L1, Pfizer, anti-PD-L1, opdivo

Pfizer has signed a multi-billion dollar deal to develop one of Merck KGaA’s investigational drugs, MSB0010718C, an anti-PD-L1 antibody. The …

The Gateway to Local Adoption Series

Latest content